Cargando…
COVID-19 pandemic response varies by clinical trial sponsor type
INTRODUCTION: The COVID-19 pandemic has impacted millions of lives globally. To learn more about this disease and find potential diagnostic, therapeutic, and preventative products, the healthcare community has initiated a staggering number of clinical trials. METHODS: ClinicalTrials.gov was reviewed...
Autores principales: | Cooper, Lisa, Lee, Irene, Waldron Lechner, Doreen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220021/ https://www.ncbi.nlm.nih.gov/pubmed/34192064 http://dx.doi.org/10.1017/cts.2021.25 |
Ejemplares similares
-
48842 Sponsor types of US interventional COVID-19 studies listed in ClinicalTrials.gov
por: Lee, Irene, et al.
Publicado: (2021) -
Challenges in Tuberculosis Clinical Trials in the Face of the COVID-19 Pandemic: A Sponsor’s Perspective
por: Rusen, I.D.
Publicado: (2020) -
Challenges and opportunities for sponsors in conducting clinical trials during a pandemic
por: Davis, Sanish, et al.
Publicado: (2020) -
Medical Journals, Academia, and Industry-Sponsored Clinical Trials
por: Frighi, Valeria
Publicado: (2005) -
Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016)